AccelStor’s NeoSapphire P710 Empowers the Cloud Infrastructure
AccelStor, the software-defined all-flash array (AFA) provider, is pleased to announce its participation in this year’s Cloud Expo Europe, taking place from March 15-16 at ExCel in London. AccelStor will exhibit in booth number 862.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170308005014/en/
AccelStor will showcase their flagship NeoSapphire P710 AFA at the show. The most powerful model in the series, the P710 delivers extreme high-performance of 700K+ IOPS for 4KB random writes in a single storage appliance and offers abundant software functionality while preserving outstanding performance. These features make the P710 an optimal solution for cloud infrastructure and VDI applications.
In today’s world, virtualisation is widely implemented for both enterprise and cloud computing. Primary applications include ERP services, databases, OLTP, testing, and online deployment services. Storage plays a vital role in the cloud infrastructure, and selecting the best storage solution is critical to success.
Mr. Alan Lin, Senior Manager of AccelStor, will present on March 16 from 12:45 to 13:10 in the Infrastructure, Storage & Virtualisation Theatre. He will address how to maximize storage performance with AFAs in the virtualisation environment, including highlighting the must-have features of AFAs and the benefits of running hypervisors with AccelStor AFAs.
Mr. Lin states, “Cloud computing and virtualisation have quickly surfaced as key facets of organizations as they evaluate ways to enhance the pace and growth of their business. At AccelStor, we believe storage plays a vital part in the newest wave of IT development. We created our NeoSapphire all-flash arrays and FlexiRemap flash-oriented software to provide businesses with the best means to evolve their cloud infrastructures and virtualisation environments.”
NeoSapphire P710 Features:
- Extreme performance with sustained 700K IOPS for 4KB random writes
- Supports 6 x 10GbE or 4 x 16G Fibre Channel connectivity
- 2U rack mount with 24 hot-swappable SSDs, including 2 global hot spares
- VMware Ready and VAAI Block Certified
NeoSapphire P710 Benefits:
- Abundant software features for VDI applications
- Free clone, snapshot, snapshot backup/restoration enhances data protection
- vSphere Web Client plug-in enables seamless integration with VMware solutions
For product details and specifications, visit the NeoSapphire P710 product page at https://www.accelstor.com/overview.php?id=19 .
About AccelStor, Inc.
AccelStor is accelerating the paradigm shift from conventional disk arrays to modern all-flash storage. AccelStor's NeoSapphire all-flash arrays, powered by FlexiRemap software technology, deliver sustained high IOPS to business-critical applications. With streamlined storage management, multi-protocol support, and front-access, hot-swappable solid-state drives, the NeoSapphire series promises to resolve performance bottlenecks for I/O-intensive applications like virtualisation, high-performance computing, database, and media processing. For more information about AccelStor and NeoSapphire, please visit www.accelstor.com .
* AccelStor, FlexiRemap, and NeoSapphire are trademarks or registered trademarks of AccelStor, Inc. in the United States of America and/or other countries.
Clara Lee, +886 2 77467616 ext. 2561
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
MA-TAKEDA/SEATTLE10.12.2017 14:02 | pressemeddelelse
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
ASTRAZENECA9.12.2017 19:02 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
JANSSEN9.12.2017 18:21 | pressemeddelelse
Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3.5 Year Follow-up Data of Imbruvica®▼(ibrutinib)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum